Commercialization: Page 22
-
PharmaVoice Team/PharmaVoice
HealthTech
Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials Trend Watch: Technologies Continue to Enhance Clinical Trial Experience and Efficiency Ochsner Health System, Louisiana’s largest non-profit academic healthcare system, and Pfizer have entered into a multi-...
By PharmaVoice Team • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Study: What Consumers Think About AI Trend Watch: From robots to analytics, AI is being used for better patient care and engagement A study commissioned by Pegasystems, “What consumers really think about AI: A global study," revealed consumers are open to the use of AI when it comes to their hea...
By PharmaVoice Team • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
From Patient to Advocate Donna Cryer, President and CEO of the Global Liver Institute, talks about how she channeled her personal experience as an IBD and liver transplant patient into professional advocacy. PV: Tell us about your journey as a patient. Cryer: This is the 25th anniversary of my li...
By Donna Cryer • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Patients Are Waiting…
Patient-focused initiatives are taking hold throughout the industry from R&D through commercialization, yet there is still room for improvement. Progress is being made to include patient insights and perspectives throughout the life-sciences more holistically. Companies are engaging patients ...
By Taren Grom • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Patient-Based Culture
Companies need to cultivate patient-centricity from the inside out. Not much more than five years ago, UCB was one of the first pharma companies to bring patient centeredness deep into its culture, moving away from the traditional product-based model driven by revenue growth and sales toward the ...
By PharmaVoice Team • April 1, 2019 -
PharmaVoice Team/PharmaVoice
The Evolving Role of Patient Advocates
Patient advocacy groups have long had relationships with pharma, and now, individual patients are also sharing their voices and their power. While pharma has long had relationships with advocacy organizations, there is a growing wave of individual patients who are willing to speak up, be engaged,...
By PharmaVoice Team • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Children on the Frontline: the Toll of Rare Diseases
Parents are the strongest advocates for their children suffering with rare diseases, pushing researchers, companies and regulatory authorities to do more to save their loved ones. For the 350 million people worldwide battling with a rare disease, the impact on their day-to-day lives is profound. ...
By Kim Ribbink • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Patient-Focused Drug Development
Biopharma companies and regulators are working to put the patient truly at the center of drug research and development. Empowered patients are redefining the healthcare environment on their own terms. Today, patients and advocates are playing a more central and proactive role in managing their ow...
By PharmaVoice Team • April 1, 2019 -
PharmaVoice Team/PharmaVoice
Patients and Regulatory Support
Regulators are working to make sure patients have a seat at the clinical trial table. The Food and Drug Administration has been instrumental in the movement toward patient-centric clinical trial initiatives and driving these initiatives forward is the future of trial development. In recent years,...
By Denise Myshko • April 1, 2019 -
PharmaVoice Team/PharmaVoice
The Caregiver Gap
Caregivers are often an integral part of the care team and are involved in everything from medication choice to adherence. Caregivers are significant players in the healthcare ecosystem and, for many individuals, a necessary part of managing an illness or chronic condition. Caregivers provide an ...
By Denise Myshko • April 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Brand Building: Brand Awareness in a Patient-Centric Era
Today, pharmaceuticals, biotech products, and other treatments are part of a broader approach to healthcare that encompasses preventative tools, wellness, and patient or consumer preference. The pharmaceutical industry no longer exists in a silo. How companies build their brands and brand awarene...
By PharmaVoice Team • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Once Upon A Time in Marketing
Have you noticed how many “storytellers" there are in our industry today? Just do a search on LinkedIn. There are brand and strategy storytellers. Heads of digital storytelling. Storytellers-in-chief. Seemingly legions of people in the business of storytelling. You could certainly dismiss it as a...
By Lou Iovino • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Customer-Centric Brand Building
The pharmaceutical company landscape is transforming. With this evolution, brand portfolios range from mass production of products for chronic diseases affecting large portions of populations, to development of novel treatments for rare diseases and personalized medicine. Today, we have the domin...
By Brandie Linfante • March 1, 2019 -
PharmaVoice Team/PharmaVoice
People + Purpose + Progress: Making Healthcare Brands More Relevant in Today's Changing Market
My favorite definition of a brand is the one that goes “a brand is something that lives between your ears." A more tangible description comes from author James Gregory who says, “a brand is the sum total of all the images, ideas, and experiences associated with that brand." So when we ask ourselv...
By Johanna Skilling • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Customer Co-Creation: Engaging and Activating Advisors
Leveraging Design Thinking to Uncover Better Real World Solutions in Advisory Boards Traditional Advisory Boards are Broken These are real quotes we have collected from colleagues and clients across the life sciences industry over the past few years. The idea of engaging customers to better under...
By Drew Beck • March 1, 2019 -
PharmaVoice Team/PharmaVoice
The Big Deal About Small Data
Big data gets all the hype, but the power of small data cannot be overlooked. Small data is mighty. Small data is small enough for human comprehension, in a volume and format that are accessible, informative, and actionable. Certainly, big data has gotten a lot of hype over the past few years, bu...
By Robin Robinson • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Picture Perfect: Instagram's Place in Pharmaceutical Engagement
Instagram is a robust social media forum with more than 1 billion monthly active users, but success depends on understanding how to harness its visual power. What do photo sharing and the pharmaceutical industry have in common? The answer is a lot more than you might expect. Instagram has become ...
By Kim Ribbink • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Executive Perspective: A New Beginning: The Future of Global Communications
When two veteran healthcare advertising executives decide to rejoin forces, the natural — and expected — assumption is that they would launch a new, differentiated, potentially funky, boutique-type communications agency. Well, Matt Giegerich and Shaun Urban are doing anything but the expected. Th...
By Matt Giegerich • March 1, 2019 -
PharmaVoice Team/PharmaVoice
Upfront
Bayer Ups its Pledge for Science Learning Experiments For Children Bayer has pledged 5 million hands-on science learning experiments for children in the United States by 2025. The milestone, if achieved, will correspond with the 30th anniversary of Bayer’s award-winning commitment to science, tec...
By PharmaVoice Team • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Health Tech
POPS! Blood Glucose Test Attaches To Smartphone Trend Watch: Medical Devices Support Patient Monitoring from Head to Toe Minneapolis-based POPS! Diabetes Care received FDA clearance for its blood glucose monitoring system that can be adhered to the back of a smartphone. Readings are taken via bui...
By PharmaVoice Team • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Transformation: Ready, Set, Agile
According to McKinsey, companies that have enterprise agility share some commonalities: a North Star-mentality, in other words an overarching customer strategy; a scalable team structure; a rapid decision-making mentality; a dynamic people model that ignites passion; and a willing adoption of nex...
By PharmaVoice Team • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Outsourcing - M&A on the Rise
Pharmaceutical outsourcing remains big business, as companies cut internal costs and with the rise of smaller specialist companies focused on rare diseases and genomics-based therapies. The move to outsource is growing, with reports that companies are turning to partners more now than they did fi...
By PharmaVoice Team • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Outsourcing Regulatory Filings with an FTE Model: Five Keys to Consider
As an increasing number of drug and device developers focus their efforts on reducing costs so they can invest more heavily in their core R&D functions, it’s no surprise that the outsourcing market for healthcare regulatory affairs is predicted to expand at a rapid pace over the next decade. ...
By Clareece West • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Rare Disease: Rare Difficulties: Finding Cures and Tackling Costs
The day-to-day lives of people with rare diseases is often poorly understood. And those with rare diseases face many challenges. Whether it’s going to work or studying, completing daily tasks such as preparing meals and shopping, or simply managing their health, the impact disease has on patients...
By PharmaVoice Team • Feb. 1, 2019 -
PharmaVoice Team/PharmaVoice
Raising One Voice for the Millions Impacted by Rare Disease
Next-generation technologies in medicine have opened new doors for identifying rare diseases and developing better and more targeted rare disease treatments. Remarkable advancements in global research efforts have already made an impact on the lives of patients living with hundreds of rare diseas...
By Meredith Gartner • Feb. 1, 2019
Previous
